Regulation of In Situ to Invasive Breast Carcinoma Transition
Min Hu(Harvard University), Kornélia Polyák(Dana-Farber Cancer Institute), Jun Yao(The University of Texas MD Anderson Cancer Center), Andrea Richardson(Brigham and Women's Hospital), Shelia M. Violette(Biogen (United States)), Stanislawa Weremowicz(Brigham and Women's Hospital), Danielle Carroll(AstraZeneca (United Kingdom)), Rebecca Gelman(Dana-Farber Cancer Institute), William C. Hahn(Broad Institute), Yuri Nikolsky(Johns Hopkins University), Mina J. Bissell(Lawrence Berkeley National Laboratory), Haiyan Chen(Harvard University), Craig Allred(Nottingham City Hospital), Tatiana Nikolskaya(Russian Academy of Sciences), Erica L. Bauerlein(Harvard University), Daniel R. Carrasco(Brigham and Women's Hospital), Stuart J. Schnitt(Brigham and Women's Hospital)
Cited by 509
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k